You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hypertension, blood pressure, LCZ696, dual inhibitor, neprilysin, NEP inhibition, vasopeptidase, ARNi, angiotensin receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)

Recruiting
  • Heart Failure
  • LCZ 696
  • +4 more
  • New Haven, Connecticut
    Yale New Haven Hospital
Dec 27, 2022

Hypertrophic Cardiomyopathy Trial in Worldwide (Lifestyle, Sacubitril/Valsartan)

Completed
  • Hypertrophic Cardiomyopathy
  • Regensburg, Germany
  • +4 more
Nov 23, 2022

Hypertrophic Cardiomyopathy Trial in Newcastle (Sacubitril/Valsartan, Lifestyle)

Completed
  • Hypertrophic Cardiomyopathy
  • Newcastle, United Kingdom
    Newcastle NHS
May 4, 2022

Hypertension, Left Ventricular Hypertrophy Trial in Shanghai (sacubitril/valsartan, Amlodipine)

Recruiting
  • Hypertension
  • Left Ventricular Hypertrophy
  • Shanghai, China
    Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
Dec 7, 2021

Hypertension, Atrial Fibrillation Trial in Beijing (Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI)

Not yet recruiting
  • Hypertension
  • Atrial Fibrillation
  • Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Apr 23, 2023

Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

Not yet recruiting
  • Aortic Valve Stenosis
  • Angiotensin Receptor-Neprilysin Inhibitor
  • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 4, 2023

Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Porto, Portugal
  • +3 more
Aug 9, 2023

Atrial Remodeling, Myocardial Dysfunction, Left Ventricular Remodeling Trial in Dun Laoghaire, Dublin (Sacubitril-Valsartan,

Active, not recruiting
  • Atrial Remodeling
  • +8 more
  • Dun Laoghaire, Co Dublin, Ireland
  • +1 more
May 10, 2021

Novel Antidiabetic Drug Combined With Angiotensin

Recruiting
  • Type 2 Diabetes
  • Antidiabetic Drugs
    • Beijing, Beijing, China
    • +1 more
    Jun 20, 2023

    Heart Failure Trial in Cairo (myocardial function after surgery)

    Recruiting
    • Heart Failure
    • myocardial function after surgery
    • Cairo, Egypt
    • +1 more
    Oct 13, 2023

    Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Danville (Pharmacist co-management, CDS, Focused Education)

    Recruiting
    • Heart Failure
    • Heart Failure With Reduced Ejection Fraction
    • Pharmacist co-management
    • +2 more
    • Danville, Pennsylvania
      Geisinger Cardiology Clinics
    Aug 11, 2023

    Acute Heart Failure Trial

    Not yet recruiting
    • Acute Heart Failure
      • (no location specified)
      May 9, 2023

      Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])

      Completed
      • Pulmonary Hypertension
      • Sacubitril / Valsartan Oral Tablet [Entresto]
      • Badalona, Barcelona, Spain
        Germans Trias i Pujol University Hospital
      Sep 23, 2021

      Obesity, Cardiovascular Diseases, Hypertension Trial in Birmingham (Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet, Valsartan 80

      Recruiting
      • Obesity
      • +5 more
      • Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet
      • Valsartan 80 mg Oral Tablet
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jun 6, 2022

      PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo

      Recruiting
      • PreDiabetes
      • +3 more
      • Sacubitril-Valsartan Tab 97-103 MG
      • +2 more
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center
      Jul 21, 2022

      Heart Failure With Preserved Ejection Fraction Trial in Chongqing (Angiotensin Receptor-Neprilysin Inhibition, Placebo)

      Not yet recruiting
      • Heart Failure With Preserved Ejection Fraction
      • Angiotensin Receptor-Neprilysin Inhibition
      • Placebo
      • Chongqing, China
        The first affiliated Hospital of Chongqing Medical University
      Oct 21, 2021

      Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

      Not yet recruiting
      • Chronic Kidney Disease
      • Part A - Lorundrostat QD + Dapaglifozin QD
      • +2 more
      • (no location specified)
      Nov 27, 2023

      Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)

      Recruiting
      • Chagas Cardiomyopathy
      • Sacubitril / Valsartan Oral Tablet [Entresto]
      • Enalapril
      • São Paulo, Brazil
        Heart Institute (Incor) University of Sao Paulo
      May 6, 2021

      Heart Failure, Exercise Tolerance, Vasodilation Trial in São Paulo (Neprilysin, Enalapril)

      Completed
      • Heart Failure
      • +4 more
      • São Paulo, SP, Brazil
        Marcelo Rodrigues dos Santos
      Oct 21, 2020

      Heart Failure With Preserved Ejection Fraction Trial (Sacubitril-Valsartan)

      Withdrawn
      • Heart Failure With Preserved Ejection Fraction
      • (no location specified)
      Aug 24, 2021

      Heart Failure With Preserved Ejection Fraction Trial in Rochester (Entresto™ 49Mg-51 mg tablet)

      Completed
      Has Results
      • Heart Failure With Preserved Ejection Fraction
      • Entresto™ 49Mg-51 mg tablet
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 6, 2022

      Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)

      Recruiting
      • Proteinuria
      • +3 more
      • Hanzhou, Zhejiang, China
        the Second Afficiated Hospital, Zhejiang University, School of M
      Feb 22, 2023

      Stage D Heart Failure Trial in Cleveland (Sacubitril-Valsartan, Usual care (standard-of-care) arm)

      Recruiting
      • Stage D Heart Failure
      • Cleveland, Ohio
        Cleveland Clinic
      Jun 4, 2021

      Diabetes, Type 2, Diastolic Dysfunction Trial in Rochester (LCZ 696, Placebos)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Diastolic Dysfunction
      • LCZ 696
      • Placebos
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Oct 12, 2021

      Heart Failure Trial in United States (LCZ696, valsartan, LCZ696 )

      Completed
      Has Results
      • Heart Failure
      • Beverly Hills, California
      • +37 more
      Dec 2, 2021